Reply #8: not Merck. They have some big issues

[still_one]

for one the lawsuits regarding regarding the cox II inhibitors is still ongoing

Another is that many of their patents will be going off

but the most important is that they do NOT have that many products in the pipeline

The cost of getting a drug approved in the United States is an extremely long and costly process, and as much as people like to constantly dis the big pharmeceutical companies, they are going to have a very difficult time